Dangers of the New GLP-1 Weight-Loss Drugs

Dangers of the New GLP-1 Weight-Loss Drugs

Each month North American doctors write more than three million prescriptions for the new weight-loss medications called GLP-1 agonists. Examples include semaglutide in Ozempic and Wegovy and tirzepatide, the drug in Mounjaro and Zepbound. Also each year, these...